May 13, 2015
Alzheimer's Association Applauds 21st Century Cures Legislation; Calls on Reaffirmed Commitment to 2025 Goal
Alzheimer's disease is addressed in the draft 21st Century Cures legislation in several key sections, including Patient and Caregiver Engagement in Drug Development, Data Sharing and Clinical Trial Modernization. The Alzheimer's Association applauds provisions to address the Alzheimer's epidemic in the current legislation but encourages vigilance for other important priorities in the National Plan to Address Alzheimer's Disease, adopted in 2012 at the direction of the 2011 National Alzheimer's Project Act.
May 5, 2015
Alzheimer's Association launches new open access journal
Reflecting significant changes in journal publishing and acknowledging the importance of biomarkers to advancing Alzheimer’s disease research, the Alzheimer’s Association and Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association introduce a new open access journal, creating an additional channel for Alzheimer’s and dementia researchers to communicate scientific findings and knowledge. The journal, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM), serves as a companion to the Association’s flagship journal.
April 29, 2015
Alzheimer's Association calls for urgency with Alzheimer's costs projected to exceed $1 trillion
Robert Egge, Alzheimer's Association executive vice president of government affairs, testified before the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies today regarding fiscal year 2016 appropriations for Alzheimer’s-related research and activities. Egge projected costs from Alzheimer’s disease, already America’s most expensive disease according to the New England Journal of Medicine, will exceed $1 trillion by 2050 if nothing is done to alter its trajectory.
April 16, 2015
Major new research study to demonstrate value of PET scans in Alzheimer's disease diagnosis
A new four-year research study, with an estimated budget of $100 million, was announced today by the Alzheimer's Association and the American College of Radiology (ACR). The Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study will determine the clinical usefulness and value in diagnosing Alzheimer's and other dementias in certain situations of a brain positron emission tomography (PET) scan that detects a core feature of Alzheimer's disease.
March 25, 2015
B. Smith addresses Senate Aging Committee hearing on need to invest in Alzheimer's research
Earlier today, the U.S. Senate Special Committee on Aging convened a hearing titled "The Fight Against Alzheimer's Disease: Are We on Track to a Treatment by 2025?" The hearing featured personal testimony from Dr. Ronald Petersen of the Mayo Clinic, a leading Alzheimer's researcher and former Alzheimer's Association National Board member; B. Smith, former model, restaurateur, retailer, author and actor, who has been diagnosed with younger-onset Alzheimer's disease; and Smith's husband, Dan Gasby.
March 25, 2015
HOPE for Alzheimer's Act introduced to improve coverage and access to critical care planning
The Alzheimer's Association strongly supports the bipartisan Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act, which was reintroduced in Congress today by Sens. Debbie Stabenow (D-Mich.) and Susan Collins (R-Maine) and Reps. Chris Smith (R-N.J.) and Paul Tonko (D-N.Y)
March 24, 2015
New Alzheimer’s Association report finds less than half of people with Alzheimer’s disease say they were told the diagnosis
The Alzheimer’s Association’s 2015 Alzheimer's Disease Facts and Figures report, released today, found that only 45 percent of people with Alzheimer’s disease or their caregivers say they were told the diagnosis by their doctor.
March 10, 2015
Advisory Council to the National Alzheimer's Project Act issues recommendations and addresses funding
With 10 years left to reach the primary goal of the National Plan to Address Alzheimer's Disease, the Advisory Council on Research, Care and Services for the National Alzheimer's Project shared recommendations for ensuring a strategic and productive update to the plan in spring 2015 with Congress and Health and Human Services (HHS) Secretary Sylvia Burwell.
March 5, 2015
Leading research funders build on global initiative with new nearly $2 million commitment to study commonalities of neurodegenerative diseases
The Alzheimer's Association is collaborating with worldwide research leaders to launch Biomarkers Across Neurodegenerative Diseases (BAND), a program to intestigate the overlap in biology and clinical symptoms of Alzheimer's, Parkinson's, frontotemporal dementia and other brain-deteriorating diseases.
February 22, 2015
Alzheimer's Association congratulates Julianne Moore on her Best Actress Academy Award win
The Alzheimer's Association congratulates Julianne Moore on winning the Oscar for Best Actress at the 87th Annual Academy Awards. Playing the title character in the film "Still Alice," Moore’s poignant portrayal of a woman diagnosed with younger-onset Alzheimer's disease illustrates the impact of Alzheimer's, the sixth-leading cause of death in the United States, on individuals and their families.
February 22, 2015
Alzheimer's Association salutes Glen Campbell on his Academy Award nomination for Best Original Song
The Alzheimer's Association thanks and salutes Glen Campbell and Julian Raymond for the song "I'm Not Gonna Miss You," that was among the Academy Award nominees for Best Original Song, during the Oscar ceremony this evening. The Association also celebrates the dedication and devotion of the Campbell family, "Glen Campbell: I'll Be Me" documentary producers James Keach and Trevor Albert, the members of the Wrecking Crew who performed on the recording of "I'm Not Gonna Miss You," and Tim McGraw for his beautiful performance of the song in honor of Glen Campbell during the 87th Academy Awards.
February 17, 2015
Alzheimer's Association statement on People of the State of New York vs. Actavis and Forest Laboratories
As the leading voluntary health organization in Alzheimer's disease care, support and research, the Alzheimer’s Association has a long-held and firm belief that people with Alzheimer’s and other dementias should have affordable access to treatments available today as well as to prevention and effective treatments in the future.
February 11, 2015
Alzheimer's Association, Weston Brain Institute and Alzheimer's Research UK join forces to form initiative to fund vital brain disease research
Three leading research funders from the UK and North America have joined forces to launch a new global initiative called MEND, or MEchanisms of cellular death in NeuroDegeneration, with a fund of $1.25 million (£820,000/$1.56CDN) for targeted research into brain diseases that cause dementia, such as Alzheimer's.
February 5, 2015
The discovery of Alzheimer's disease treatment by 2025 will save the U.S. $220 billion within first five years
The United States could save $220 billion within the first five years of a treatment for Alzheimer's disease being introduced, according to a new report from the Alzheimer's Association.
February 2, 2015
President's budget acknowledges Alzheimer's disease as unchecked threat but does not meet urgent funding needs
President Barack Obama's fiscal year 2016 budget recognizes the unique threat posed by Alzheimer's, the most expensive disease in the nation and the only leading cause of death in the United States with no way to prevent, stop or even slow its progression, calling for a $51 million increase in Alzheimer's research. However, without increasing funding to the levels deemed necessary by the scientific community, America is unlikely to complete the primary goal of the National Plan to Address Alzheimer's Disease to prevent and effectively treat Alzheimer's disease by 2025.
January 26, 2015
New Alzheimer's Association research grants accelerate studies of potential Alzheimer's drug therapies
The Alzheimer's Association has announced new grant awards for five early-phase clinical trials. The grants are funded through the Alzheimer's Association Part the Cloud Translational Research for Alzheimer's Disease initiative, which supports research critical to transitioning early, exploratory laboratory studies to Phase 1 clinical drug trials in humans. The new awards total nearly $4 million, increasing the total amount awarded through the initiative since its inception to $6 million.
January 14, 2015
Scientists look to heart disease and stroke-related disorders for clues to preventing and treating Alzheimer’s
Recommendations by a group of scientists to bolster research on how Alzheimer’s disease and vascular conditions progress together and influence each other are available online today, in advance of publication, by Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. The authors hope this research agenda, if executed, will uncover new clues for effectively treating or preventing dementia.